See today’s BioWorld MedTech
Metsystem receives injection of funds to validate cancer metastasis prognosis platform
MEDWATCH 22.3.2023
Entrepreneurs create prognosis service for hospitals: Will identify patients at high risk of metastases.
Newly founded Metsystem aims to make its prognosis service available in 2025 initially to hospitals in Denmark, but later abroad and to pharmaceutical companies as a test of their cancer treatment in the preclinical stage.
